Heart failure with preserved ejection fraction: Defining the function of ROS and NO. (Q38482322)

3 September 2017

1 reference

title

Heart failure with preserved ejection fraction: Defining the function of ROS and NO. (English)

1 reference

Heart failure with preserved ejection fraction

3 September 2017

1 reference

1 reference

Li Zuo

1

1 reference

3 September 2017

Chia-Chen Chuang

series ordinal

2

1 reference

3 September 2017

Benjamin T Hemmelgarn

series ordinal

3

1 reference

3 September 2017

Thomas M Best

series ordinal

4

1 reference

3 September 2017

language of work or name

English

0 references

publication date

14 May 2015

1 reference

Journal of Applied Physiology

3 September 2017

1 reference

3 September 2017

119

1 reference

3 September 2017

944-951

1 reference

3 September 2017

8

1 reference

Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling

3 September 2017

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Myocardial energetics and ubiquinol in diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Nitric oxide synthases in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

The role of inflammatory and fibrogenic pathways in heart failure associated with aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Chemistry and biology of reactive oxygen species in signaling or stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Signal transduction by reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Nitric oxide synthases: regulation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Exercise-induced cardiac preconditioning: how exercise protects your achy-breaky heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Redox-dependent increases in glutathione reductase and exercise preconditioning: role of NADPH oxidase and mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Novel aspects of ROS signalling in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Exercise preconditioning of the myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Bioelectrochemistry, reactive oxygen species, receptors, and cell signaling: how interrelated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Apocynin attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Meta-analysis of the effect of statins on mortality in patients with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Regulation of myocardial growth and death by NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Nitric oxide and cardiac function: ten years after, and continuing

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Trends in prevalence and outcome of heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

The pathophysiology of heart failure with preserved ejection fraction: from molecular mechanisms to exercise haemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Mechanisms of exercise-induced cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Neutrophil extracellular trap cell death requires both autophagy and superoxide generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Free radicals in biology: oxidative stress and the effects of ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Folic acid reverses nitric oxide synthase uncoupling and prevents cardiac dysfunction in insulin resistance: role of Ca2+/calmodulin-activated protein kinase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Redox regulation of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Role of oxidants on calcium and sodium movement in healthy and diseased cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Mitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Cardiomyocytes as effectors of nitric oxide signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Inflammation and metabolic dysfunction: links to cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Tetrahydrobiopterin in nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Crosstalk between fibroblasts and inflammatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpoint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

ROS signalling between endothelial cells and cardiac cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Oxidative and nitrosative stress in the maintenance of myocardial function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

Heart failure with preserved ejection fraction: emerging drug strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.01149.2014

10.1152/JAPPLPHYSIOL.01149.2014

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference